These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8102619

  • 1. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence.
    Noguchi Y, Tsuburaya A, Makino T, Fukuzawa K, Nomura K, Yoshikawa T, Imada T, Amano T, Matsumoto A.
    Int Surg; 1993; 78(2):107-11. PubMed ID: 8102619
    [Abstract] [Full Text] [Related]

  • 2. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
    Orita H, Maehara Y, Emi Y, Kakeji Y, Baba H, Korenaga D, Sugimachi K.
    Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
    [Abstract] [Full Text] [Related]

  • 3. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 4. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M.
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
    Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T.
    Cancer Res; 1991 Feb 01; 51(3):1034-8. PubMed ID: 1670998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [DNA content and c-erbB-2 oncoprotein expression in hepatic metastases from colorectal carcinoma--in relation to clinicopathologic findings and prognosis].
    Omori K.
    Nihon Geka Gakkai Zasshi; 1991 Oct 01; 92(10):1469-79. PubMed ID: 1961185
    [Abstract] [Full Text] [Related]

  • 10. Is DNA aneuploidy a prognostic factor in gastric cancer?
    Omejc M, Repse S, Bracko M.
    Acta Chir Hung; 1997 Oct 01; 36(1-4):266-9. PubMed ID: 9408370
    [Abstract] [Full Text] [Related]

  • 11. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K, Furui J, Kohara N, Izawa K, Kanematsu T, Shiku H.
    Surgery; 1994 Mar 01; 115(3):349-54. PubMed ID: 7907434
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S, Bertoni F, Zanella L, Setola E, Bacchini P, Alberghini M, Versari M, Bacci G.
    Cancer; 2004 May 01; 100(9):1936-42. PubMed ID: 15112275
    [Abstract] [Full Text] [Related]

  • 16. [Expression of c-erbB-2 protein and vessel invasion in colorectal cancer].
    Yamaguchi S, Ohki S, Jo T, Imai S, Matsuo K, Hamahata Y, Fukano M, Tokito S, Hasegawa S, Masui H.
    Gan To Kagaku Ryoho; 1992 Jan 01; 19(1):34-9. PubMed ID: 1346087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.
    Cancer; 2003 Feb 01; 97(3):545-53. PubMed ID: 12548595
    [Abstract] [Full Text] [Related]

  • 19. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Feb 01; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP, Lundin J, Nordling S, Kokkola A, Haglund C.
    Anticancer Res; 2008 Feb 01; 28(4C):2279-87. PubMed ID: 18751407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.